No.	Time	Submission ID	Full Name	Abstract Topic	Abstract Title
BEST ORAL COMMUNICATION \| 7 MARCH 2026
1	0900 – 0915	OP-0058	Richard Gallon	Lynch Syndrome	The Newcastle MSI-Plus Assay for low cost and scalable Lynch syndrome screening of cancer patients and urine-based early detection of Lynch syndrome urothelial cancer
2	0915 – 0930	OP-0038	GABRIELE PICCO	Lynch Syndrome	TA-Repeat Expansions Drive WRN Dependency and Guide Inhibitor Therapy in Sporadic and Lynch-Associated MSI Cancers
3	0930 – 0945	EI-0097	Jared R Hendren	Familial Adenomatous Polyposis	Comparison of postoperative morbidity following total colectomy with ileorectal anastomosis vs proctocolectomy with ileal pouch-anal anastomosis in familial adenomatous polyposis
4	0945 – 1000	EI-0118	Robert Hüneburg	Familial Adenomatous Polyposis	Cap-assisted vs. side-viewing duodenoscopy for papilla visualization in familial adenomatous polyposis: a randomized blinded cross-over trial (CAPFAP)
5	1000 – 1015	EI-0010	Monique van Leerdam	Familial Adenomatous Polyposis	PANCREATIC CANCER SURVEILLANCE NOT RECOMMENDED FOR FAMILIAL ADENOMATOUS POLYPOSIS: A FINE AND GRAY RISK ANALYSIS
6	1015 – 1030	OP-0028	Aysel Ahadova	Lynch Syndrome	Systemic markers for predicting and monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: a pilot study
ABSTRACT PRESENTATION 1 \| 4 MARCH 2026
7	1500 – 1510	OP-0064	Luis G Carvajal Carmona	Artificial Intelligence in Risk Assessment	Improving Colorectal Cancer Risk Prediction in Latinos Using Polygenic Scores and Machine Learning
8	1510 – 1520	OP-0065	Raj Ramesar	Studies in Asia and Underrepresented Populations	The Familial Cancer Experience in South Africa: A Model for Implementing Genomic Medicine in Developing Countries
9	1520 – 1530	EI-0011	Heather Hampel	Lynch Syndrome	Lynch Syndrome Re-Defined Through a Universal Germline Genetic Testing Program
10	1530 – 1540	OP-0041	Tan Wan Ling Andrea	Artificial Intelligence in Risk Assessment	Improving Hereditary GI Cancer Referral Rates using Electronic Health Records
ABSTRACT PRESENTATION 2 \| 4 MARCH 2026
11	1650 – 1700	PP-0030	Sara Tasnim	Lynch Syndrome	Cost-effectiveness of Genetic Testing to Diagnose Lynch Syndrome in Singapore
12	1700 – 1710	OP-0013	Agnes Wong	Health Policy and Equity	Decision Regret and Willingness to Pay for Cancer Genetic Testing: A Longitudinal Contingent Valuation Study
13	1710 – 1720	EI-0137	Carla Oliveira	Hereditary Gastric Cancer Syndromes	Clinical Outcomes and Healthcare Costs in Hereditary Diffuse Gastric Cancer: A European Multicenter Study
14	1720 – 1730	EI-0028	Alicia Latham	Lynch Syndrome	Feasibility of Pap-derived cfDNA for early-detection of sporadic and Lynch-associated endometrial and ovarian cancers
ABSTRACT PRESENTATION 3 \| 5 MARCH 2026
15	0910 – 0920	OP-0027	Aysel Ahadova	Lynch Syndrome	Somatic CTNNB1 mutations as a positive predictor of Lynch syndrome
16	0920 – 0930	EI-0012	Taina T Nieminen	Novel Genes in Hereditary GI Tumours	Inflammasome-related gene variant predisposing to familial colorectal carcinoma
17	0930 – 0940	OP-0011	Noah Cornelis Helderman	Lynch Syndrome	Immune infiltration in Lynch syndrome colorectal cancer is linked to diagnostic context, not MMR gene defect
18	0940 – 0950	OP-0014	István Kelemen	Lynch Syndrome	Peripheral immunophenotyping reveals cancer-related alterations in Lynch syndrome
19	0950 – 1000	EI-0108	Jacob Nattermann	Lynch Syndrome	Remodeling of the Intestinal Immune Infiltrate and Integrin Signatures of Tissue- Resident CD8⁺ T Cells in Lynch Syndrome
20	1000 – 1010	EI-0142	Nicole Cianci	Lynch Syndrome	Pre-empting Vaccine Barriers in Lynch Syndrome: Profiling Immune Evasion Across Precancerous Progression
ABSTRACT PRESENTATION 4 \| 5 MARCH 2026
21	1120 – 1130	EI-0039	Olkinuora Alisa	Novel Genes in Hereditary GI Tumours	Evidence for MLH3 as a cause for colorectal polyposis – a multinational study
22	1130 – 1140	OP-0047	Jihoon E. Joo	Other Polyposis Syndromes	Molecular landscapes of colorectal polyps and cancers from serrated polyposis syndrome patients with germline RNF43 variants
23	1140 – 1150	OP-0043	Daniel Buchanan	Novel Genes in Hereditary GI Tumours	Germline pathogenic variants in homologous recombination repair pathway genes and the presence of the homologous recombination deficiency mutational signature in early-onset colorectal cancer
24	1150 – 1200	EI-0087	Sunam Mander	Pediatric Hereditary GI Tumour Syndromes	Towards prevention of replication repair deficient childhood cancers using neoantigen mRNA-LNP Vaccine
25	1200 – 1210	EI-0072	Laura Valle	Other Polyposis Syndromes	Clinical, molecular, and functional insights into POLE and POLD1 proofreading deficiency
26	1210 – 1220	OP-0062	Matthias Kloor	Lynch Syndrome	Mismatch repair deficiency in histologically normal appearing normal urothelium in Lynch syndrome carriers
27	1220 – 1230	OP-0052	Giovana Tardin Torrezan	Lynch Syndrome	Investigating somatic and rare germline mechanisms in patients with unexplained mismatch repair deficiency
ABSTRACT PRESENTATION 5 \| 5 MARCH 2026
28	1430 – 1440	EI-0067	Andrew Latchford	Familial Adenomatous Polyposis	Defining the risk of desmoid disease following surgery in familial adenomatous polyposis (FAP) patients with a low risk genotype
29	1440 – 1450	EI-0007	Benjamin Zare	Familial Adenomatous Polyposis	Defining the picture of desmoid disease in children and young adults with familial adenomatous polyposis
30	1450 – 1500	EI-0114	Marco Vitellaro	Familial Adenomatous Polyposis	Novel Endoscopic Classification for Duodenal Polyposis in Individuals with Familial Adenomatous Polyposis: the DRACO multi-center study.
31	1500 – 1510	OP-0010	Noah Cornelis Helderman	Other Polyposis Syndromes	Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9
32	1510 – 1520	EI-0089	Divya L Deverakonda, MD	Familial Adenomatous Polyposis	Outcomes following endoscopic versus transduodenal resection in FAP patients with duodenal adenomas: a meta-analysis
33	1520 – 1530	EI-0049	Susan Clark	Familial Adenomatous Polyposis	Comparison of desmoid disease risk after prophylactic minimally invasive versus open restorative proctocolectomy in patients with FAP
34	1530 – 1540	OP-0040	Yen Lin Chu	Microbiome and Environmental Modifiers	The role of genotoxic gut bacteria in serrated polyposis syndrome and unexplained adenomatous polyposis
ABSTRACT PRESENTATION 6 \| 5 MARCH 2026
35	1650 – 1700	OP-0045	Jihoon E. Joo	Familial Adenomatous Polyposis	Using Oxford Nanopore Technologies long-read sequencing to resolve unexplained hereditary colorectal cancer and polyposis syndrome patients
36	1700 – 1710	EI-0127	Roshani Patel	Other Polyposis Syndromes	Small bowel surveillance investigations, interventions and outcomes in a large UK Peutz-Jeghers syndrome cohort
37	1710 – 1720	EI-0037	Imogen Bennett	Other Polyposis Syndromes	Duodenal involvement in MUTYH-associated polyposis: findings from an international prospective study and implications for endoscopic surveillance
38	1720 – 1730	OP-0023	Stephen B. Gruber	Novel Genes in Hereditary GI Tumours	Risk of Colorectal Cancer in Li Fraumeni Syndrome
39	1730 – 1740	EI-0052	Benjamin Zare	Familial Adenomatous Polyposis	Molecular and clinicopathological profiling of desmoid tumours in familial adenomatous polyposis through RNA sequencing analysis.
ABSTRACT PRESENTATION 7 \| 6 MARCH 2026
40	0910 – 0920	EI-0088	Carol Burke	Familial Adenomatous Polyposis	Clinical Outcomes and Management of Gastric White Mucosal Patches in Patients with Familial Adenomatous Polyposis
41	0920 – 0930	EI-0020	Ophir Gilad	Hereditary Gastric Cancer Syndromes	Penetrance of CDH1 Pathogenic Variants: A Multicenter Analysis from the GASTRIC Consortium
42	0930 – 0940	EI-0125	Victoria Cuthill	Other Polyposis Syndromes	Outcomes of gastric surveillance in juvenile polyposis syndrome
43	0940 – 0950	EI-0130	Robert Hüneburg	Familial Adenomatous Polyposis	Longitudinal analysis of fundic gland cysts as predictors of gastric neoplasia in familial adenomatous polyposis
ABSTRACT PRESENTATION 8 \| 6 MARCH 2026
44	1140 – 1150	EI-0063	Nur Diana Binte Ishak	Hereditary Pancreatic Cancer Syndromes	Prevalence Of Germline Pathogenic Variants Among Pancreatic Cancer Patients in Singapore
45	1150 – 1200	EI-0083	Kasmintan A Schrader	Hereditary Pancreatic Cancer Syndromes	Parent-of-Origin-Aware genomic analysis Enhances the Genetic Risk Assessment in Pancreatic Ductal Adenocarcinoma
46	1200 – 1210	EI-0003	Asaf Maoz	Hereditary Pancreatic Cancer Syndromes	Yield of Germline Genetic Testing among Families with Pancreatic Cancer Clustering
47	1210 – 1220	EI-0054	Zewen Zhang	Hereditary Pancreatic Cancer Syndromes	Clinical Characteristics and Outcomes of Pancreatic Cancer Patients with Germline HRD Mutations: A Retrospective Cohort Study
48	1220 – 1230	EI-0009	Monique van Leerdam	Lynch Syndrome	LYNCH SYNDROME – PANCREATIC CANCER RISK AND SURVIVAL: A NATIONWIDE DUTCH COHORT STUDY
49	1230 – 1240	EI-0124	Sari Lieberman	Hereditary Pancreatic Cancer Syndromes	Gastrointestinal cancer risks in Israeli BRCA1/BRCA2 mutation carriers
ABSTRACT PRESENTATION 9 \| 6 MARCH 2026
50	1420 – 1430	EI-0022	Stephanie Poo	Lynch Syndrome	A systematic review and meta-analysis on colorectal neoplasia detection in Lynch syndrome
51	1430 – 1440	OP-0026	Carol A. Burke	Lynch Syndrome	Incidence And Predictors of Advanced Neoplasia In Patients with Lynch Syndrome on Surveillance Colonoscopy Performed at or after Age 65 years
52	1440 – 1450	PP-0028	Luigi Ricciardiello	Lynch Syndrome	Adenoma Incidence Trends by Genotype in Lynch Syndrome: A Retrospective Cohort Study of 318 MD Anderson Cancer Center Patients
53	1450 – 1500	OP-0005	Kevin Monahan	Lynch Syndrome	Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: an observational cohort study
54	1500 – 1510	OP-0048	Hugo MONTEMONT	Lynch Syndrome	Non-Neoplastic Precursor Lesions and Somatic Alterations in Lynch Syndrome–Associated Upper Gastrointestinal Cancers
55	1510 – 1520	EI-0140	Tim Marwitz	Artificial Intelligence in Risk Assessment	Potential impact of AI-assisted colonoscopy on non-AI performance in Lynch syndrome surveillance: evidence of a skill effect
56	1520 – 1530	EI-0133	Srividhya Sainath	Lynch Syndrome	Deep Learning Model Distinguishes Lynch Syndrome from Sporadic MSI-H using Adenoma Histology
ABSTRACT PRESENTATION 10 \| 6 MARCH 2026
57	1620 – 1630	OP-0042	Romy Walker	Hereditary Gastric Cancer Syndromes	Cancer risks in first-degree relatives of individuals with biallelic somatic DNA mismatch repair mutations
58	1630 – 1640	EI-0013	Anthony Scott	Lynch Syndrome	A multiplex assay of variant effect (MAVE) of MSH6 enables accurate, prospective Lynch Syndrome clinical variant interpretation
59	1640 – 1650	PP-0018	Hashini Kristhorubaduge	Lynch Syndrome	Reassessing MSH6 variants in ClinVar using MMR-specific ACMG/AMP guidelines and recent literature
60	1650 – 1700	EI-0047	Aimee L. Lucas	Lynch Syndrome	Immunogenic frameshift mutations in patients with Lynch syndrome and immune suppression programs supporting colorectal cancer development
61	1700 – 1710	OP-0029	Mattia Boeri	Lynch Syndrome	Prospective Evaluation of a Blood-Based Digital PCR MSI Assay for Early Colorectal Cancer Detection in Lynch Syndrome Carriers: the BioLynch Study
62	1710 – 1720	EI-0110	Penelope Edwards	Lynch Syndrome	Blood-based T cell clonal expansion as a biomarker of mismatch repair-deficient tumours in Lynch syndrome
63	1720 – 1730	EI-0036	Penelope Edwards	Lynch Syndrome	Mapping the T Cell Receptor Repertoire in Lynch Syndrome-Associated Colorectal Cancer
64	1730 – 1740	EI-0147	Joaquín Castillo-Iturra	Lynch Syndrome	Neoantigen-loaded dendritic cell vaccine for cancer prevention in Lynch Syndrome: Early results from a phase Ib clinical trial

Poster Display Panels

Submission ID	Poster Panel Number	First Author	Country/Region	Abstract Topic	Row	Session
EI-0033	122	Aasem Abu Shtaya	Israel	Germline Mosaicism in Hereditary GI Tumours	4	A
EI-0034	130	Aasem Abu Shtaya	Israel	Health Policy and Equity	5	A
EI-0032	137	Aasem Abu Shtaya	Israel	Studies in Asia and Underrepresented Populations	5	A
EI-0006	4	Akinari Takao	Japan	Lynch Syndrome	1	A
EI-0060	13	Akira Sakamoto	Japan	Lynch Syndrome	1	B
EI-0042	154	Alessandro Mannucci	Italy	Implementation Science in Hereditary Cancer	5	A
EI-0120	31	Alethea Tang	United Kingdom	Lynch Syndrome	1	A
EI-0102	22	Alvin Wei Tian Ng	Singapore	Lynch Syndrome	1	A
EI-0109	121	Alysha Prisc	Australia	Microbiome and Environmental Modifiers	4	A
OP-0004	41	Amalia Nicole Nanciu	Germany	Lynch Syndrome	2	A
OP-0002	94	Amalia Nicole Nanciu	Germany	Other Polyposis Syndromes	4	B
EI-0068	64	Andrew Latchford	United Kingdom	Familial Adenomatous Polyposis	3	A
EI-0053	63	Anisha Sukha	United Kingdom	Familial Adenomatous Polyposis	3	A
EI-0005	3	Anja Wagner	Netherlands	Lynch Syndrome	1	A
EI-0075	17	Anja Wagner	Netherlands	Lynch Syndrome	1	B
EI-0080	18	Anja Wagner	Netherlands	Lynch Syndrome	1	B
EI-0094	112	Anjeli Manam	United States	Hereditary Pancreatic Cancer Syndromes	4	A
OP-0033	44	Anna Magdalena Scheßl	Germany	Lynch Syndrome	2	A
EI-0135	71	Anne-Sophie Layritz	Germany	Familial Adenomatous Polyposis	3	A
EI-0143	38	Ann-Sofie Backman	Sweden	Lynch Syndrome	1	B
EI-0008	135	Anthony Vladimir Campos Se	Brazil	Studies in Asia and Underrepresented Populations	5	A
EI-0119	30	Antonia Schuler	Germany	Lynch Syndrome	1	A
EI-0121	32	Antonia Schuler	Germany	Lynch Syndrome	1	B
EI-0123	34	Antonia Schuler	Germany	Lynch Syndrome	1	B
PP-0035	55	Ashwini Wijeweera	Singapore	Lynch Syndrome	2	B
EI-0021	6	Atsushi Yamada	Japan	Lynch Syndrome	1	A
OP-0044	47	Aung Ko Win	Australia	Lynch Syndrome	2	A
EI-0122	33	Benedito Mauro Rossi	Brazil	Lynch Syndrome	1	B
EI-0051	62	Benjamin Zare	United Kingdom	Familial Adenomatous Polyposis	3	A
PP-0031	115	Ben-Yehoyada, Merav	Israel	Hereditary Pancreatic Cancer Syndromes	4	B
EI-0015	5	Brandie Heald Leach	United States	Lynch Syndrome	1	A
EI-0093	20	Bryson Katona	United States	Lynch Syndrome	1	A
EI-0086	103	Bryson Katona	United States	Hereditary Gastric Cancer Syndromes	4	A
EI-0106	142	Caitlin Nicole Samy Victoria	Singapore	Studies in Asia and Underrepresented Populations	5	B
EI-0048	138	Chayanin Kasidajpong	Thailand	Studies in Asia and Underrepresented Populations	5	A
PP-0032	81	Chrystelle Colas	Switzerland	Familial Adenomatous Polyposis	3	B
PP-0027	158	Claresta Yeo Chyi Maey	Singapore	Implementation Science in Hereditary Cancer	5	B
OP-0034	96	Claudia Monaco	Italy	Other Polyposis Syndromes	4	B
EI-0065	14	Clorinda Brignola	Italy	Lynch Syndrome	1	B
PP-0001	113	Colas Chrystelle	France	Hereditary Pancreatic Cancer Syndromes	4	B
EI-0113	27	Davide Ferrari	Italy	Lynch Syndrome	1	A
EI-0084	87	Diantha Terlouw	Netherlands	Other Polyposis Syndromes	4	A
PP-0025	80	Diya Porwal	Singapore	Familial Adenomatous Polyposis	3	B
PP-0011	128	Dr Warren Hyer	United Kingdom	Pediatric Hereditary GI Tumour Syndromes	4	B
OP-0049	48	Elizabeth Half	Israel	Lynch Syndrome	2	A
EI-0016	110	Erez Hasnis	Israel	Hereditary Pancreatic Cancer Syndromes	4	A
EI-0139	119	Frances Victoria F. Ǫue	Philippines	Novel Genes in Hereditary GI Tumours	4	B
EI-0050	11	Frances Victoria Ǫue	Philippines	Lynch Syndrome	1	A
EI-0092	65	Frances Victoria Ǫue	Philippines	Familial Adenomatous Polyposis	3	A
PP-0029	53	Francisco López	Chile	Lynch Syndrome	2	B
OP-0056	126	Gabriel Capellá	Spain	Pediatric Hereditary GI Tumour Syndromes	4	B
EI-0073	16	Giada Sassi	Italy	Lynch Syndrome	1	B
OP-0055	105	Giovana Tardin Torrezan	Brazil	Hereditary Gastric Cancer Syndromes	4	A
EI-0030	102	Gregory Idos	United States	Hereditary Gastric Cancer Syndromes	4	A
EI-0079	148	Hashini Kristhorubaduge	Australia	Artificial Intelligence in Risk Assessment	5	A
EI-0040	61	Hicham Bouchiba	Netherlands	Familial Adenomatous Polyposis	3	A
OP-0019	74	Hicham Bouchiba	Netherlands	Familial Adenomatous Polyposis	3	B
OP-0031	76	Hicham Bouchiba	Netherlands	Familial Adenomatous Polyposis	3	B
EI-0002	2	Hidetaka Kawamura	Japan	Lynch Syndrome	1	A
OP-0020	104	Hidewaki Nakagawa	Japan	Hereditary Gastric Cancer Syndromes	4	A
PP-0010	161	Hiroko Fujita	Japan	Non-Physician Providers in Cancer Management	5	B
OP-0008	152	Hiroto Narimatsu	Japan	Digital Health in Hereditary GI Cancer	5	A
EI-0014	136	Hong-Min Ahn	South Korea	Studies in Asia and Underrepresented Populations	5	A
PP-0020	52	Hyeon Hee Lee	Republic Of Korea	Lynch Syndrome	2	A
OP-0012	73	Iddo Bar-Yishay	Israel	Familial Adenomatous Polyposis	3	B
EI-0074	86	Imogen Bennett	United Kingdom	Other Polyposis Syndromes	4	A
EI-0116	29	Irene A. Caspers	Netherlands	Lynch Syndrome	1	A
EI-0019	84	John-Paul Plazzer	Australia	Other Polyposis Syndromes	4	A
EI-0069	85	James Cockburn	United Kingdom	Other Polyposis Syndromes	4	A
PP-0044	58	Janina Bazalar-Palacios	Norway	Lynch Syndrome	2	B
PP-0045	59	Janina Bazalar-Palacios	Peru	Lynch Syndrome	2	B
EI-0099	89	Jared Hendren	United States	Other Polyposis Syndromes	4	A
EI-0101	90	Jared Hendren	United States	Other Polyposis Syndromes	4	A
EI-0103	23	Jared R Hendren	United States	Lynch Syndrome	1	A
EI-0096	88	Jared R Hendren	United States	Other Polyposis Syndromes	4	A
EI-0058	131	Jeanette Yuen	Singapore	Health Policy and Equity	5	A
EI-0057	140	Jeanette Yuen	Singapore	Studies in Asia and Underrepresented Populations	5	B
EI-0059	141	Jeanette Yuen	Singapore	Studies in Asia and Underrepresented Populations	5	B
EI-0056	12	Jeff Crimson San Jose Ordoñe	Philippines	Lynch Syndrome	1	B
PP-0006	78	Jessica Emadi-Cork	United Kingdom	Familial Adenomatous Polyposis	3	B
OP-0007	160	Jessica Emadi-Cork	United Kingdom	Non-Physician Providers in Cancer Management	5	B
EI-0115	28	Jessica Vadaketh	United States	Lynch Syndrome	1	A
PP-0022	101	Jianglei Wu	Singapore	Other Polyposis Syndromes	4	B
PP-0043	57	Joaquín Castillo-Iturra	Spain	Lynch Syndrome	2	B
PP-0015	162	Kana Yamatogi	Japan	Non-Physician Providers in Cancer Management	5	B
EI-0117	67	Karin Álvarez	Norway	Familial Adenomatous Polyposis	3	A
EI-0134	37	Katarina Dian Andini	Netherlands	Lynch Syndrome	1	B
EI-0111	25	Katrin van Beekum	Germany	Lynch Syndrome	1	A
EI-0112	26	Katrin van Beekum	Germany	Lynch Syndrome	1	A
PP-0040	147	Katrina R. Ellis	United States	Studies in Asia and Underrepresented Populations	5	B
PP-0005	77	Kazuhito Sasaki	Japan	Familial Adenomatous Polyposis	3	B
EI-0081	150	Kelly Kohut	United Kingdom	Digital Health in Hereditary GI Cancer	5	A
EI-0090	157	Kevin Monahan	United States	Implementation Science in Hereditary Cancer	5	B
EI-0107	91	Khalid Mahmood	Australia	Other Polyposis Syndromes	4	A
EI-0126	35	Kimia Mohammadsaeedi	Australia	Lynch Syndrome	1	B
OP-0036	45	Ladan goshayeshi	Iran	Lynch Syndrome	2	A
EI-0141	92	Laura Valle	Spain	Other Polyposis Syndromes	4	A
EI-0070	116	Laura Valle	Spain	Novel Genes in Hereditary GI Tumours	4	B
EI-0076	117	Laura Valle	Spain	Novel Genes in Hereditary GI Tumours	4	B
PP-0036	146	Li Shao-Tzu	Singapore	Studies in Asia and Underrepresented Populations	5	B
PP-0014	129	Lin Zhenhan Isaac	Singapore	Pediatric Hereditary GI Tumour Syndromes	4	B
EI-0078	111	Linda M. Polfus	United States	Hereditary Pancreatic Cancer Syndromes	4	A
OP-0063	106	Luis G Carvajal-Carmona	United States	Hereditary Gastric Cancer Syndromes	4	A
PP-0009	99	Maartje Nielsen	Netherlands	Other Polyposis Syndromes	4	B
PP-0017	108	Manasadevi Karthikeyan	Singapore	Hereditary Gastric Cancer Syndromes	4	A
OP-0037	46	Marjorie de la Fuente	Chile	Lynch Syndrome	2	A
OP-0057	50	Marta Pineda	Spain	Lynch Syndrome	2	A
OP-0059	127	Marta Pineda	Spain	Pediatric Hereditary GI Tumour Syndromes	4	B
EI-0062	155	Marta Puzzono	Italy	Implementation Science in Hereditary Cancer	5	A
EI-0071	156	Marta Puzzono	Italy	Implementation Science in Hereditary Cancer	5	B
PP-0034	145	Mashu Futagawa	Japan	Studies in Asia and Underrepresented Populations	5	B
EI-0128	68	Mathijs J. Mol	Netherlands	Familial Adenomatous Polyposis	3	A
EI-0129	69	Mathijs J. Mol	Netherlands	Familial Adenomatous Polyposis	3	A
OP-0061	149	Matthias Kloor	Germany	Artificial Intelligence in Risk Assessment	5	A
EI-0098	21	Maurizio Genuardi	Italy	Lynch Syndrome	1	A
EI-0144	39	Megan Hitchins	United States	Lynch Syndrome	1	B
OP-0050	49	Mev Dominguez Valentin	Norway	Lynch Syndrome	2	A
EI-0138	151	Michelle Jacobs	United States	Digital Health in Hereditary GI Cancer	5	A
PP-0024	109	Minmin Li	Australia	Hereditary Gastric Cancer Syndromes	4	A
PP-0023	79	Momoko Araki	Japan	Familial Adenomatous Polyposis	3	B
PP-0021	114	Monika Koudová	Czech Republic	Hereditary Pancreatic Cancer Syndromes	4	B
EI-0077	124	Nicholas Fernandez	Canada	Pediatric Hereditary GI Tumour Syndromes	4	A
PP-0008	98	Noah Cornelis Helderman	Netherlands	Other Polyposis Syndromes	4	B
PP-0046	82	Nur Hikmah Fitriyah	Singapore	Familial Adenomatous Polyposis	3	B
OP-0030	75	Patrizia Pasanisi	Italy	Familial Adenomatous Polyposis	3	B
OP-0046	120	Peh Yean Cheah	Singapore	Novel Genes in Hereditary GI Tumours	4	B
OP-0039	97	Peter Georgeson	Australia	Other Polyposis Syndromes	4	B
EI-0104	24	Reagan Barnett	United States	Lynch Syndrome	1	A
OP-0053	133	Rebecca Caeser	Singapore	Health Policy and Equity	5	A
OP-0051	153	Rebecca Caeser	Singapore	Digital Health in Hereditary GI Cancer	5	A
EI-0132	70	Ripple Man	United Kingdom	Familial Adenomatous Polyposis	3	A
OP-0021	42	Robert Hüneburg	Germany	Lynch Syndrome	2	A
EI-0001	1	Robert Rudolf Kikkert	Netherlands	Lynch Syndrome	1	A
EI-0082	132	Roshani Patel	United Kingdom	Health Policy and Equity	5	A
EI-0105	118	Ruby Clarissa Sutopo	Singapore	Novel Genes in Hereditary GI Tumours	4	B
EI-0055	139	Rutharra Ghayadthri Manisek	Singapore	Studies in Asia and Underrepresented Populations	5	A
PP-0013	100	Ryan O’Keeffe	Australia	Other Polyposis Syndromes	4	B
EI-0146	72	Samuel J. Klempner	United States	Familial Adenomatous Polyposis	3	A
EI-0004	60	Saurin Jean Christophe	France	Familial Adenomatous Polyposis	3	A
OP-0060	51	Sean Shi-An Lim	Singapore	Lynch Syndrome	2	A
EI-0035	123	Shlomi Cohen	Israel	Pediatric Hereditary GI Tumour Syndromes	4	A
OP-0001	93	Shoko Miyahara	Japan	Other Polyposis Syndromes	4	A
EI-0038	8	Simeen Malik	Singapore	Lynch Syndrome	1	A
EI-0091	19	Sonia Kupfer	United States	Lynch Syndrome	1	B
OP-0006	95	Stefan Aretz	Germany	Other Polyposis Syndromes	4	B
EI-0145	40	Stephanie X. Poo	United Kingdom	Lynch Syndrome	1	A
EI-0027	7	Susan Parry	New Zealand	Lynch Syndrome	1	A
OP-0024	43	Swati G Patel	United States	Lynch Syndrome	2	A
PP-0026	134	Tan Yu Bin	Singapore	Health Policy and Equity	5	A
PP-0003	143	Tan Yu Bin	Singapore	Studies in Asia and Underrepresented Populations	5	B
PP-0033	54	Tasmyn Scriven	Singapore	Lynch Syndrome	2	B
PP-0016	144	Tatsuro Yamaguchi	Japan	Studies in Asia and Underrepresented Populations	5	B
EI-0061	159	Tiffany Lim	Singapore	Non-Physician Providers in Cancer Management	5	B
PP-0002	107	Tomomi Oka	Japan	Hereditary Gastric Cancer Syndromes	4	B
EI-0136	125	Tomomitsu Sado	Japan	Pediatric Hereditary GI Tumour Syndromes	4	A
EI-0043	9	Uri Tabori	Canada	Lynch Syndrome	1	A
EI-0131	36	Vanessa García López-Mingo	Netherlands	Lynch Syndrome	1	B
PP-0042	56	Walaa Alshaia	United States	Lynch Syndrome	2	B
EI-0017	83	Wu Wing Kwan Claudia	Hong Kong SAR	Other Polyposis Syndromes	4	A
EI-0066	15	Yong Ǫuan Lee	Australia	Lynch Syndrome	1	B
EI-0095	66	Yoon Sook Yee	Malaysia	Familial Adenomatous Polyposis	3	A
EI-0044	10	Zoya Aamir	Canada	Lynch Syndrome	1	A

5 March 2026
Session A: 12:30 – 13:50
Session B: 17:40 – 18:40

The programme is accurate as of 27 February 2026 and is subject to change at the discretion of the Organising Committee without prior notice. Detailed information regarding presentation times, venues, and panel numbers will be shared in due course.All updates will be made available on our website.

CONTACT US

Kenes MP Asia Pte Ltd

20 Kallang Avenue, PICO Creative Centre, Level 2

Singapore 339411

General Inquiries

info@insight2026.org

Registration Inquiries

registration@insight2026.org

Abstract Inquiries

abstract@insight2026.org

Hotel	Validity	Per Adult			Per Child
Hotel	Validity	Single Sharing (SGD)	Twin Sharing (SGD)	Triple Sharing (SGD)	Child With Bed (SGD)	Child No Bed (SGD)
Harris Hotel & Suites Nagoya Batam	8 – 10 Mar 2026	292	210	210	185	122
Grand Mercure	8 – 10 Mar 2026	395	260	251	226	132

Hotel	Validity	Per Adult			Per Child
Hotel	Validity	Single Sharing (SGD)	Twin Sharing (SGD)	Triple Sharing (SGD)	Child With Bed (SGD)	Child No Bed (SGD)
Harris Hotel & Suites Nagoya Batam	8 – 10 Mar 2026	292	210	210	185	122
Grand Mercure	8 – 10 Mar 2026	395	260	251	226	132

Hotel	Validity	Per Adult			Per Child
Hotel	Validity	Single Sharing (SGD)	Twin Sharing (SGD)	Triple Sharing (SGD)	Child With Bed (SGD)	Child No Bed (SGD)
Harris Hotel & Suites Nagoya Batam	8 – 10 Mar 2026	277	196	196	185	122
Grand Mercure	8 – 10 Mar 2026	380	246	236	226	132

Hotel	Validity	Per Adult
Hotel	Validity	Single Sharing (SGD)	Twin Sharing (SGD)	Triple Sharing (SGD)
Sylvia Resort Komodo / Luwansa Beach Resort	8 – 10 Mar 2026	1518	948	713
Bintang Flores Hotel / LAPRIMA Hotel	8 – 10 Mar 2026	1568	1005	764

Hotel	Validity	Per Adult
Hotel	Validity	Single Sharing (SGD)	Twin Sharing (SGD)	Triple Sharing (SGD)
ibis Yogyakarta Adi Sucipto	8 – 10 Mar 2026	552	503	462
Santika Premiere Yogyakarta	8 – 10 Mar 2026	556	506	465
Melia Purosani Yogyakarta	8 – 10 Mar 2026	609	560	520

Accepted Abstracts

Oral Presentation Slots

Poster Display Panels

Oral Presentation Slots

Poster Display Panels

CONTACT US

Prof John BurnUnited Kingdom

Dr David ChurchEngland

Dr Laura Valle Velasco

Emeritus Prof Allan Spigelman

Prof Finlay Macrae

Dr Kevin Monahan

Dr Rashid Lui

Ms Brandie Leach

Dr Andrew Latchford

Dr Matthew Kalady

A/Prof Mustak Ibn Ayub

Dr Marc Greenblatt

Dr Ian Frayling

A/Prof Daniel Buchanan

Dr Francesc Balaguer

Dr Tan Yu Bin

Adj A/Prof Surendra Kumar Mantoo

Adj A/Prof Yeo Yen Ching

A/Prof Sunny Wong

Dr Lee Ser Yee

Prof Jon Emery

Dr Kieron Lim

Prof Khay Guan Yeoh

Prof Patrick Tan

Prof Joseph Sung

A/Prof Joanne Ngeow

3 Days 2 Nights: Ranoh Island Package

3 Days 2 Nights: Batam Tour with 1-hr Massage

3 Days 2 Nights: Batam Tour

3 Days 2 Nights: Labuan Bajo – Komodo Island Package

3 Days 2 Nights: Yogyakarta

3 Days 2 Nights Bali Free and Easy

3 Days 2 Nights: Penang Free & Easy

3 Days 2 Nights: Genting

3 Days 2 Nights: Kuala Lumpur

Prof John Burn
United Kingdom

Dr David Church
England